Asimov is a synthetic biology startup dedicated to advancing the design of living systems to enable biotechnologies that significantly benefit society. The company is developing a mammalian synthetic biology platform that integrates cells and software, facilitating the creation and manufacture of next-generation therapeutics. Asimov operates with a vision to transform biological engineering into a comprehensive discipline, pushing the boundaries of how living systems are engineered. The company values diversity and collaboration, emphasizing a culture of recombination where different backgrounds and perspectives are essential to achieving its mission. Teams at Asimov consist of a mix of scientists, engineers, and business professionals who work together to drive innovation in the field of synthetic biology.